Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid elongation (GO:0030497) | 7.75960552 |
2 | ensheathment of neurons (GO:0007272) | 6.21762237 |
3 | axon ensheathment (GO:0008366) | 6.21762237 |
4 | myelination (GO:0042552) | 6.15815497 |
5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.03116314 |
6 | synaptic vesicle maturation (GO:0016188) | 5.36762714 |
7 | glutamate secretion (GO:0014047) | 5.06916657 |
8 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.97397060 |
9 | myelin maintenance (GO:0043217) | 4.96527871 |
10 | cholesterol biosynthetic process (GO:0006695) | 4.95753771 |
11 | cellular potassium ion homeostasis (GO:0030007) | 4.89863259 |
12 | negative regulation of neurotransmitter transport (GO:0051589) | 4.79555704 |
13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.79290854 |
14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.62744487 |
15 | synaptic vesicle exocytosis (GO:0016079) | 4.53597502 |
16 | sterol biosynthetic process (GO:0016126) | 4.39743864 |
17 | oligodendrocyte differentiation (GO:0048709) | 4.37520335 |
18 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.36577782 |
19 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.35412719 |
20 | regulation of collateral sprouting (GO:0048670) | 4.25589232 |
21 | neuronal ion channel clustering (GO:0045161) | 4.21783162 |
22 | sodium ion export (GO:0071436) | 4.16655891 |
23 | eye photoreceptor cell differentiation (GO:0001754) | 4.16400084 |
24 | photoreceptor cell differentiation (GO:0046530) | 4.16400084 |
25 | negative regulation of protein localization to cell surface (GO:2000009) | 4.15215825 |
26 | substantia nigra development (GO:0021762) | 4.14385846 |
27 | potassium ion import (GO:0010107) | 4.11110792 |
28 | regulation of synaptic vesicle transport (GO:1902803) | 4.07078320 |
29 | presynaptic membrane organization (GO:0097090) | 4.03026158 |
30 | postsynaptic membrane organization (GO:0001941) | 4.02750692 |
31 | amyloid precursor protein metabolic process (GO:0042982) | 3.99885016 |
32 | isoprenoid biosynthetic process (GO:0008299) | 3.94833897 |
33 | neuronal action potential propagation (GO:0019227) | 3.91546374 |
34 | presynaptic membrane assembly (GO:0097105) | 3.90832289 |
35 | positive regulation of actin filament depolymerization (GO:0030836) | 3.86627913 |
36 | acidic amino acid transport (GO:0015800) | 3.86330384 |
37 | neurotransmitter secretion (GO:0007269) | 3.85263794 |
38 | protein neddylation (GO:0045116) | 3.81190202 |
39 | potassium ion homeostasis (GO:0055075) | 3.80260448 |
40 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.78964046 |
41 | response to redox state (GO:0051775) | 3.78867380 |
42 | long-term synaptic potentiation (GO:0060291) | 3.76287724 |
43 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.68928760 |
44 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.68483565 |
45 | locomotory exploration behavior (GO:0035641) | 3.67357372 |
46 | cytidine metabolic process (GO:0046087) | 3.66938457 |
47 | cytidine catabolic process (GO:0006216) | 3.66938457 |
48 | cytidine deamination (GO:0009972) | 3.66938457 |
49 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.62389724 |
50 | glycerophospholipid catabolic process (GO:0046475) | 3.60066453 |
51 | limb bud formation (GO:0060174) | 3.57276745 |
52 | apical protein localization (GO:0045176) | 3.54489974 |
53 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.54425154 |
54 | response to methylmercury (GO:0051597) | 3.53627739 |
55 | establishment of mitochondrion localization (GO:0051654) | 3.52890177 |
56 | virion attachment to host cell (GO:0019062) | 3.52015693 |
57 | adhesion of symbiont to host cell (GO:0044650) | 3.52015693 |
58 | glycosphingolipid biosynthetic process (GO:0006688) | 3.50094604 |
59 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.50028258 |
60 | L-glutamate transport (GO:0015813) | 3.47998521 |
61 | creatine metabolic process (GO:0006600) | 3.47417120 |
62 | astrocyte development (GO:0014002) | 3.44106907 |
63 | response to lipoprotein particle (GO:0055094) | 3.43449308 |
64 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.42983291 |
65 | asymmetric protein localization (GO:0008105) | 3.42905983 |
66 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.42321762 |
67 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.40858907 |
68 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.40099522 |
69 | neurotransmitter transport (GO:0006836) | 3.33384381 |
70 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31287757 |
71 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.31095669 |
72 | astrocyte differentiation (GO:0048708) | 3.28087663 |
73 | DNA deamination (GO:0045006) | 3.26614610 |
74 | detection of calcium ion (GO:0005513) | 3.25786222 |
75 | signal peptide processing (GO:0006465) | 3.24301328 |
76 | gamma-aminobutyric acid transport (GO:0015812) | 3.24217119 |
77 | synaptic transmission, glutamatergic (GO:0035249) | 3.21960224 |
78 | amyloid precursor protein catabolic process (GO:0042987) | 3.20200774 |
79 | GPI anchor biosynthetic process (GO:0006506) | 3.18649792 |
80 | nucleotide transmembrane transport (GO:1901679) | 3.18071886 |
81 | neuron-neuron synaptic transmission (GO:0007270) | 3.17829336 |
82 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.17579658 |
83 | response to lead ion (GO:0010288) | 3.17272411 |
84 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.15163723 |
85 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.14425943 |
86 | regulation of neurotransmitter transport (GO:0051588) | 3.14349261 |
87 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12394132 |
88 | myelination in peripheral nervous system (GO:0022011) | 3.12230741 |
89 | peripheral nervous system axon ensheathment (GO:0032292) | 3.12230741 |
90 | glutamate receptor signaling pathway (GO:0007215) | 3.11057739 |
91 | regulation of neurotransmitter levels (GO:0001505) | 3.11004293 |
92 | cerebellar granule cell differentiation (GO:0021707) | 3.10809346 |
93 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.10409385 |
94 | regulation of neurotransmitter uptake (GO:0051580) | 3.10391210 |
95 | auditory behavior (GO:0031223) | 3.09546010 |
96 | regulation of neurotransmitter secretion (GO:0046928) | 3.07248042 |
97 | magnesium ion transport (GO:0015693) | 3.05652634 |
98 | L-amino acid import (GO:0043092) | 3.04699612 |
99 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.03079391 |
100 | C4-dicarboxylate transport (GO:0015740) | 3.02511574 |
101 | neuron cell-cell adhesion (GO:0007158) | 2.99850304 |
102 | GPI anchor metabolic process (GO:0006505) | 2.99076238 |
103 | exploration behavior (GO:0035640) | 2.98892273 |
104 | regulation of dopamine metabolic process (GO:0042053) | 2.98658690 |
105 | regulation of catecholamine metabolic process (GO:0042069) | 2.98658690 |
106 | cellular sodium ion homeostasis (GO:0006883) | 2.98548207 |
107 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98070725 |
108 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.95893702 |
109 | vocalization behavior (GO:0071625) | 2.95517005 |
110 | negative regulation of JUN kinase activity (GO:0043508) | 2.95339401 |
111 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.94166733 |
112 | protein palmitoylation (GO:0018345) | 2.93300471 |
113 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.92436090 |
114 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.91917595 |
115 | negative regulation of axonogenesis (GO:0050771) | 2.90715294 |
116 | import into cell (GO:0098657) | 2.90686421 |
117 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.88743976 |
118 | regulation of cell communication by electrical coupling (GO:0010649) | 2.87878758 |
119 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.87258138 |
120 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.85219097 |
121 | negative regulation of inclusion body assembly (GO:0090084) | 2.84761089 |
122 | regulation of synaptic plasticity (GO:0048167) | 2.83964476 |
123 | neural nucleus development (GO:0048857) | 2.83565088 |
124 | positive regulation of membrane potential (GO:0045838) | 2.83549512 |
125 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.83303060 |
126 | regulation of synapse structural plasticity (GO:0051823) | 2.83074008 |
127 | response to auditory stimulus (GO:0010996) | 2.82886449 |
128 | positive regulation of interleukin-17 production (GO:0032740) | 2.80236674 |
129 | neuron remodeling (GO:0016322) | 2.80062290 |
130 | regulation of dendritic spine development (GO:0060998) | 2.78898336 |
131 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.78033901 |
132 | protein localization to synapse (GO:0035418) | 2.77745959 |
133 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.76973478 |
134 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.75643271 |
135 | axon development (GO:0061564) | 2.75568492 |
136 | glycosylceramide metabolic process (GO:0006677) | 2.75261536 |
137 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.74078271 |
138 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.73907524 |
139 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.73169382 |
140 | long-term memory (GO:0007616) | 2.72540100 |
141 | mannosylation (GO:0097502) | 2.72083183 |
142 | peripheral nervous system development (GO:0007422) | 2.71367189 |
143 | dopamine biosynthetic process (GO:0042416) | 2.71222174 |
144 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.69321605 |
145 | adult walking behavior (GO:0007628) | 2.67752107 |
146 | enteric nervous system development (GO:0048484) | 2.66969820 |
147 | regulation of memory T cell differentiation (GO:0043380) | 2.65918867 |
148 | positive regulation of action potential (GO:0045760) | 2.65238528 |
149 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.60696439 |
150 | positive regulation of cell fate commitment (GO:0010455) | 2.60632814 |
151 | positive regulation of glial cell differentiation (GO:0045687) | 2.59508701 |
152 | chaperone-mediated protein transport (GO:0072321) | 2.59485109 |
153 | positive regulation of gliogenesis (GO:0014015) | 2.58593679 |
154 | response to epinephrine (GO:0071871) | 2.58540605 |
155 | negative regulation of axon extension (GO:0030517) | 2.56259843 |
156 | membrane assembly (GO:0071709) | 2.55321869 |
157 | neurotransmitter uptake (GO:0001504) | 2.54962547 |
158 | negative regulation of exocytosis (GO:0045920) | 2.54673390 |
159 | Rap protein signal transduction (GO:0032486) | 2.53479096 |
160 | regulation of lipoprotein metabolic process (GO:0050746) | 2.53366395 |
161 | peptidyl-cysteine modification (GO:0018198) | 2.52577139 |
162 | very long-chain fatty acid metabolic process (GO:0000038) | 2.51004544 |
163 | membrane tubulation (GO:0097320) | 2.49718389 |
164 | membrane raft organization (GO:0031579) | 2.48263015 |
165 | transmission of nerve impulse (GO:0019226) | 2.47511326 |
166 | glial cell development (GO:0021782) | 2.46425228 |
167 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.44366718 |
168 | cellular response to epinephrine stimulus (GO:0071872) | 2.40534031 |
169 | amino acid import (GO:0043090) | 2.40473993 |
170 | nucleotide transport (GO:0006862) | 2.40433206 |
171 | adhesion of symbiont to host (GO:0044406) | 2.40350783 |
172 | negative regulation of acute inflammatory response (GO:0002674) | 2.40100840 |
173 | positive regulation of pseudopodium assembly (GO:0031274) | 2.39314236 |
174 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.36730205 |
175 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.36088298 |
176 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.36088298 |
177 | axon ensheathment in central nervous system (GO:0032291) | 10.3474486 |
178 | central nervous system myelination (GO:0022010) | 10.3474486 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.22844744 |
2 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.78013417 |
3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.66039993 |
4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.59638990 |
5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.51570044 |
6 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.35432016 |
7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.34842902 |
8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.31303784 |
9 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.26397461 |
10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22482648 |
11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.19033559 |
12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16535872 |
13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.16027988 |
14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.12874018 |
15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.06899322 |
16 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.05724704 |
17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.05724620 |
18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.04768096 |
19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.99626136 |
20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.94443269 |
21 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.94041589 |
22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.93542004 |
23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.93135136 |
24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.91289348 |
25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.91241020 |
26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.89318410 |
27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83067948 |
28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.73847950 |
29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73821841 |
30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.72575632 |
31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.72575632 |
32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.70096394 |
33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69582621 |
34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68333201 |
35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65080497 |
36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63163598 |
37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59633874 |
38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59517651 |
39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.59365252 |
40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59119835 |
41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57019073 |
42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.55789214 |
43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54831478 |
44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54646456 |
45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54488062 |
46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53786333 |
47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53786333 |
48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53069968 |
49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52301655 |
50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.51863100 |
51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51391653 |
52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.50721489 |
53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49768620 |
54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.49420728 |
55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47753682 |
56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47305786 |
57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.47110452 |
58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45023947 |
59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43198187 |
60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39083039 |
61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.37831635 |
62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37678916 |
63 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34751355 |
64 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33902988 |
65 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33399019 |
66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33384110 |
67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31839127 |
68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27937404 |
69 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.26793727 |
70 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.26470109 |
71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26389724 |
72 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24745440 |
73 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23952877 |
74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23542522 |
75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22268232 |
76 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21908821 |
77 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.21168354 |
78 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.19226664 |
79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.18746566 |
80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18283723 |
81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17672113 |
82 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17536232 |
83 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17498710 |
84 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.17382824 |
85 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16758181 |
86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16324162 |
87 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15008733 |
88 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14977009 |
89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14945183 |
90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14666508 |
91 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14095495 |
92 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13910376 |
93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13453673 |
94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13290782 |
95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12741948 |
96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11733470 |
97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10850924 |
98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10423476 |
99 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.09612587 |
100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09536914 |
101 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09030073 |
102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08515767 |
103 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08165322 |
104 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08042179 |
105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07939224 |
106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07433932 |
107 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07231811 |
108 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06478875 |
109 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06279725 |
110 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05740716 |
111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05441211 |
112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05406356 |
113 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.05159280 |
114 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04719718 |
115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03713843 |
116 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03591369 |
117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03438276 |
118 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02583128 |
119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02234756 |
120 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01106125 |
121 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01106125 |
122 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.00950041 |
123 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.99319728 |
124 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.99049529 |
125 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98931082 |
126 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98794198 |
127 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97950858 |
128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97903445 |
129 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97156382 |
130 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95070748 |
131 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95041189 |
132 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.93667612 |
133 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92944359 |
134 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.92250132 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000920_abnormal_myelination | 5.14472459 |
2 | MP0003880_abnormal_central_pattern | 4.12787029 |
3 | MP0003950_abnormal_plasma_membrane | 3.07734666 |
4 | MP0001529_abnormal_vocalization | 3.06462029 |
5 | MP0005171_absent_coat_pigmentation | 3.02698380 |
6 | MP0003690_abnormal_glial_cell | 2.78508998 |
7 | MP0001905_abnormal_dopamine_level | 2.75069430 |
8 | MP0004270_analgesia | 2.75033667 |
9 | MP0001984_abnormal_olfaction | 2.66125625 |
10 | MP0004742_abnormal_vestibular_system | 2.46812884 |
11 | MP0004142_abnormal_muscle_tone | 2.34915446 |
12 | MP0002272_abnormal_nervous_system | 2.25983787 |
13 | MP0003136_yellow_coat_color | 2.16042255 |
14 | MP0000383_abnormal_hair_follicle | 2.14705983 |
15 | MP0003634_abnormal_glial_cell | 2.12682881 |
16 | MP0003329_amyloid_beta_deposits | 2.04906977 |
17 | MP0004885_abnormal_endolymph | 2.02345918 |
18 | MP0001486_abnormal_startle_reflex | 2.00962221 |
19 | MP0002064_seizures | 1.97760923 |
20 | MP0004134_abnormal_chest_morphology | 1.93475115 |
21 | MP0000778_abnormal_nervous_system | 1.83105538 |
22 | MP0004381_abnormal_hair_follicle | 1.82533717 |
23 | MP0010678_abnormal_skin_adnexa | 1.77778531 |
24 | MP0001346_abnormal_lacrimal_gland | 1.77410466 |
25 | MP0001485_abnormal_pinna_reflex | 1.76710786 |
26 | MP0002734_abnormal_mechanical_nocicepti | 1.66173336 |
27 | MP0005409_darkened_coat_color | 1.64708062 |
28 | MP0008260_abnormal_autophagy | 1.64544725 |
29 | MP0009046_muscle_twitch | 1.54260923 |
30 | MP0005423_abnormal_somatic_nervous | 1.51788520 |
31 | MP0009745_abnormal_behavioral_response | 1.50841316 |
32 | MP0002229_neurodegeneration | 1.50662672 |
33 | MP0001502_abnormal_circadian_rhythm | 1.48642348 |
34 | MP0003632_abnormal_nervous_system | 1.47646847 |
35 | MP0001299_abnormal_eye_distance/ | 1.45785635 |
36 | MP0002638_abnormal_pupillary_reflex | 1.43909730 |
37 | MP0005671_abnormal_response_to | 1.41130901 |
38 | MP0005410_abnormal_fertilization | 1.36218749 |
39 | MP0004811_abnormal_neuron_physiology | 1.34817100 |
40 | MP0000462_abnormal_digestive_system | 1.33856418 |
41 | MP0005451_abnormal_body_composition | 1.33118472 |
42 | MP0006082_CNS_inflammation | 1.32235450 |
43 | MP0003635_abnormal_synaptic_transmissio | 1.30087196 |
44 | MP0003787_abnormal_imprinting | 1.26995014 |
45 | MP0001440_abnormal_grooming_behavior | 1.26086481 |
46 | MP0002557_abnormal_social/conspecific_i | 1.23755842 |
47 | MP0004043_abnormal_pH_regulation | 1.22942500 |
48 | MP0009250_abnormal_appendicular_skeleto | 1.22110539 |
49 | MP0002572_abnormal_emotion/affect_behav | 1.21196404 |
50 | MP0004859_abnormal_synaptic_plasticity | 1.21007965 |
51 | MP0002822_catalepsy | 1.19974938 |
52 | MP0008569_lethality_at_weaning | 1.18793548 |
53 | MP0000569_abnormal_digit_pigmentation | 1.18440569 |
54 | MP0003045_fibrosis | 1.18330363 |
55 | MP0000762_abnormal_tongue_morphology | 1.18037076 |
56 | MP0001970_abnormal_pain_threshold | 1.18001710 |
57 | MP0003631_nervous_system_phenotype | 1.16771285 |
58 | MP0002882_abnormal_neuron_morphology | 1.15811403 |
59 | MP0001963_abnormal_hearing_physiology | 1.15433246 |
60 | MP0008877_abnormal_DNA_methylation | 1.15171631 |
61 | MP0000566_synostosis | 1.15128225 |
62 | MP0005167_abnormal_blood-brain_barrier | 1.14261489 |
63 | MP0005253_abnormal_eye_physiology | 1.14027669 |
64 | MP0005551_abnormal_eye_electrophysiolog | 1.14012266 |
65 | MP0008438_abnormal_cutaneous_collagen | 1.13830412 |
66 | MP0001348_abnormal_lacrimal_gland | 1.13346678 |
67 | MP0000955_abnormal_spinal_cord | 1.11517302 |
68 | MP0000372_irregular_coat_pigmentation | 1.10911418 |
69 | MP0004147_increased_porphyrin_level | 1.10483193 |
70 | MP0002933_joint_inflammation | 1.09787180 |
71 | MP0002148_abnormal_hypersensitivity_rea | 1.07651901 |
72 | MP0005623_abnormal_meninges_morphology | 1.07575155 |
73 | MP0003195_calcinosis | 1.05991939 |
74 | MP0002066_abnormal_motor_capabilities/c | 1.05565095 |
75 | MP0002295_abnormal_pulmonary_circulatio | 1.04333485 |
76 | MP0002067_abnormal_sensory_capabilities | 1.02338136 |
77 | MP0002063_abnormal_learning/memory/cond | 1.01501486 |
78 | MP0004924_abnormal_behavior | 1.00119333 |
79 | MP0005386_behavior/neurological_phenoty | 1.00119333 |
80 | MP0006276_abnormal_autonomic_nervous | 0.99621700 |
81 | MP0002752_abnormal_somatic_nervous | 0.97814403 |
82 | MP0000749_muscle_degeneration | 0.97592262 |
83 | MP0001851_eye_inflammation | 0.97327418 |
84 | MP0000604_amyloidosis | 0.96761569 |
85 | MP0009780_abnormal_chondrocyte_physiolo | 0.96565048 |
86 | MP0001177_atelectasis | 0.95756879 |
87 | MP0002735_abnormal_chemical_nociception | 0.95555289 |
88 | MP0000579_abnormal_nail_morphology | 0.95488074 |
89 | MP0003633_abnormal_nervous_system | 0.94980318 |
90 | MP0005645_abnormal_hypothalamus_physiol | 0.93881541 |
91 | MP0001986_abnormal_taste_sensitivity | 0.93281639 |
92 | MP0003183_abnormal_peptide_metabolism | 0.92004780 |
93 | MP0000647_abnormal_sebaceous_gland | 0.89003356 |
94 | MP0000026_abnormal_inner_ear | 0.88773681 |
95 | MP0005408_hypopigmentation | 0.88751902 |
96 | MP0002736_abnormal_nociception_after | 0.88238781 |
97 | MP0002733_abnormal_thermal_nociception | 0.88168101 |
98 | MP0002184_abnormal_innervation | 0.87632760 |
99 | MP0005646_abnormal_pituitary_gland | 0.86017820 |
100 | MP0003075_altered_response_to | 0.84726614 |
101 | MP0006072_abnormal_retinal_apoptosis | 0.81518721 |
102 | MP0008873_increased_physiological_sensi | 0.80924976 |
103 | MP0001968_abnormal_touch/_nociception | 0.79991024 |
104 | MP0004215_abnormal_myocardial_fiber | 0.79328086 |
105 | MP0002909_abnormal_adrenal_gland | 0.77536499 |
106 | MP0003938_abnormal_ear_development | 0.76962373 |
107 | MP0000639_abnormal_adrenal_gland | 0.76687226 |
108 | MP0008872_abnormal_physiological_respon | 0.75673977 |
109 | MP0005195_abnormal_posterior_eye | 0.74940404 |
110 | MP0002152_abnormal_brain_morphology | 0.74826102 |
111 | MP0005503_abnormal_tendon_morphology | 0.74522910 |
112 | MP0001188_hyperpigmentation | 0.74348301 |
113 | MP0009384_cardiac_valve_regurgitation | 0.73783678 |
114 | MP0008874_decreased_physiological_sensi | 0.73589866 |
115 | MP0003937_abnormal_limbs/digits/tail_de | 0.72717663 |
116 | MP0005058_abnormal_lysosome_morphology | 0.71302713 |
117 | MP0005379_endocrine/exocrine_gland_phen | 0.71207863 |
118 | MP0002163_abnormal_gland_morphology | 0.71192331 |
119 | MP0002090_abnormal_vision | 0.70066537 |
120 | MP0000467_abnormal_esophagus_morphology | 0.67961836 |
121 | MP0005388_respiratory_system_phenotype | 0.67914385 |
122 | MP0002133_abnormal_respiratory_system | 0.67914385 |
123 | MP0003137_abnormal_impulse_conducting | 0.67835588 |
124 | MP0003724_increased_susceptibility_to | 0.67835570 |
125 | MP0001340_abnormal_eyelid_morphology | 0.65215082 |
126 | MP0001501_abnormal_sleep_pattern | 0.63718426 |
127 | MP0002069_abnormal_eating/drinking_beha | 0.60626142 |
128 | MP0003866_abnormal_defecation | 0.60460157 |
129 | MP0002083_premature_death | 0.52402280 |
130 | MP0003879_abnormal_hair_cell | 0.51646791 |
131 | MP0005166_decreased_susceptibility_to | 0.51157763 |
132 | MP0005535_abnormal_body_temperature | 0.50940034 |
133 | MP0003763_abnormal_thymus_physiology | 0.49775996 |
134 | MP0005165_increased_susceptibility_to | 0.49298359 |
135 | MP0002102_abnormal_ear_morphology | 0.48258881 |
136 | MP0002234_abnormal_pharynx_morphology | 0.45244801 |
137 | MP0000427_abnormal_hair_cycle | 0.45178257 |
138 | MP0002095_abnormal_skin_pigmentation | 0.43017079 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.47857697 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.47857697 |
3 | Parakeratosis (HP:0001036) | 5.45554599 |
4 | Focal motor seizures (HP:0011153) | 5.29566817 |
5 | Neurofibrillary tangles (HP:0002185) | 5.19580983 |
6 | Action tremor (HP:0002345) | 4.93125934 |
7 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.34503732 |
8 | Cerebral hypomyelination (HP:0006808) | 4.20878359 |
9 | Febrile seizures (HP:0002373) | 4.17364737 |
10 | Atonic seizures (HP:0010819) | 4.12801854 |
11 | Diplopia (HP:0000651) | 4.08897821 |
12 | Abnormality of binocular vision (HP:0011514) | 4.08897821 |
13 | Focal seizures (HP:0007359) | 4.02807288 |
14 | Peripheral hypomyelination (HP:0007182) | 3.95176170 |
15 | Sensory axonal neuropathy (HP:0003390) | 3.93272022 |
16 | Increased serum pyruvate (HP:0003542) | 3.88960129 |
17 | Abnormality of glycolysis (HP:0004366) | 3.88960129 |
18 | Abnormality of the corticospinal tract (HP:0002492) | 3.68967737 |
19 | Hemiplegia (HP:0002301) | 3.56642737 |
20 | Epileptic encephalopathy (HP:0200134) | 3.38830787 |
21 | Cerebral inclusion bodies (HP:0100314) | 3.36207763 |
22 | Leukodystrophy (HP:0002415) | 3.16419671 |
23 | Hemiparesis (HP:0001269) | 3.11915525 |
24 | Choreoathetosis (HP:0001266) | 3.08277912 |
25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.05337958 |
26 | Delusions (HP:0000746) | 3.02645394 |
27 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.01076202 |
28 | Onion bulb formation (HP:0003383) | 3.00687958 |
29 | Ankle clonus (HP:0011448) | 2.96146924 |
30 | Amyotrophic lateral sclerosis (HP:0007354) | 2.95323811 |
31 | Pheochromocytoma (HP:0002666) | 2.93459144 |
32 | Spastic tetraparesis (HP:0001285) | 2.90723985 |
33 | Tetraplegia (HP:0002445) | 2.89679276 |
34 | Alacrima (HP:0000522) | 2.89409630 |
35 | White forelock (HP:0002211) | 2.89262946 |
36 | Neuroendocrine neoplasm (HP:0100634) | 2.84448880 |
37 | Patchy hypopigmentation of hair (HP:0011365) | 2.84212509 |
38 | Abnormal auditory evoked potentials (HP:0006958) | 2.82788290 |
39 | Increased circulating renin level (HP:0000848) | 2.81825604 |
40 | Urinary urgency (HP:0000012) | 2.80992910 |
41 | Supranuclear gaze palsy (HP:0000605) | 2.80264424 |
42 | Generalized tonic-clonic seizures (HP:0002069) | 2.79529500 |
43 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.78671268 |
44 | Dysdiadochokinesis (HP:0002075) | 2.78461157 |
45 | Retinal dysplasia (HP:0007973) | 2.78128663 |
46 | Papilledema (HP:0001085) | 2.75329088 |
47 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.73004258 |
48 | Lower limb muscle weakness (HP:0007340) | 2.73003161 |
49 | Abnormal eating behavior (HP:0100738) | 2.69017241 |
50 | Autoamputation (HP:0001218) | 2.66456481 |
51 | Dialeptic seizures (HP:0011146) | 2.59862915 |
52 | T lymphocytopenia (HP:0005403) | 2.57319191 |
53 | CNS hypomyelination (HP:0003429) | 2.55688818 |
54 | Spastic gait (HP:0002064) | 2.55610199 |
55 | Hypoplastic pelvis (HP:0008839) | 2.54414958 |
56 | Premature skin wrinkling (HP:0100678) | 2.54210803 |
57 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.52642198 |
58 | Progressive cerebellar ataxia (HP:0002073) | 2.52363148 |
59 | Thickened helices (HP:0000391) | 2.51295281 |
60 | Split foot (HP:0001839) | 2.50767859 |
61 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.50559151 |
62 | Akinesia (HP:0002304) | 2.49282305 |
63 | Anxiety (HP:0000739) | 2.47800065 |
64 | Vaginal atresia (HP:0000148) | 2.45301817 |
65 | Stridor (HP:0010307) | 2.44996029 |
66 | Absent septum pellucidum (HP:0001331) | 2.43594262 |
67 | Truncal ataxia (HP:0002078) | 2.42442895 |
68 | Absence seizures (HP:0002121) | 2.42162702 |
69 | Acute necrotizing encephalopathy (HP:0006965) | 2.41917855 |
70 | Dysmetria (HP:0001310) | 2.38142648 |
71 | Methylmalonic acidemia (HP:0002912) | 2.36522038 |
72 | Slow saccadic eye movements (HP:0000514) | 2.36226066 |
73 | Morphological abnormality of the inner ear (HP:0011390) | 2.35485565 |
74 | Termporal pattern (HP:0011008) | 2.34022291 |
75 | Insidious onset (HP:0003587) | 2.34022291 |
76 | Genital tract atresia (HP:0001827) | 2.33966892 |
77 | Abnormality of T cell number (HP:0011839) | 2.33451552 |
78 | Hepatosplenomegaly (HP:0001433) | 2.31025232 |
79 | Clonus (HP:0002169) | 2.27529273 |
80 | Torticollis (HP:0000473) | 2.27488885 |
81 | Cerebral hemorrhage (HP:0001342) | 2.26307314 |
82 | Mutism (HP:0002300) | 2.22968493 |
83 | Scanning speech (HP:0002168) | 2.20709836 |
84 | Clumsiness (HP:0002312) | 2.18329887 |
85 | Postural tremor (HP:0002174) | 2.18035734 |
86 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.17605151 |
87 | Aplasia of the phalanges of the hand (HP:0009802) | 2.17605151 |
88 | Aplasia involving bones of the extremities (HP:0009825) | 2.17605151 |
89 | Decreased lacrimation (HP:0000633) | 2.15987149 |
90 | 3-Methylglutaconic aciduria (HP:0003535) | 2.14908836 |
91 | Megalencephaly (HP:0001355) | 2.08370300 |
92 | Abnormality of the septum pellucidum (HP:0007375) | 2.05405955 |
93 | Anteriorly placed anus (HP:0001545) | 2.05286949 |
94 | Metaphyseal dysplasia (HP:0100255) | 2.05049979 |
95 | Abnormality of incisor morphology (HP:0011063) | 2.04393203 |
96 | Intention tremor (HP:0002080) | 2.04198208 |
97 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.03654609 |
98 | Poor speech (HP:0002465) | 2.03476961 |
99 | Medial flaring of the eyebrow (HP:0010747) | 2.02572729 |
100 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.02345905 |
101 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.02288604 |
102 | Conical tooth (HP:0000698) | 2.01536944 |
103 | Abnormality of the periventricular white matter (HP:0002518) | 2.01180752 |
104 | Postural instability (HP:0002172) | 2.00282744 |
105 | Gait imbalance (HP:0002141) | 2.00116841 |
106 | Adrenal hypoplasia (HP:0000835) | 1.99013043 |
107 | Hypoplasia of the iris (HP:0007676) | 1.98296314 |
108 | Cupped ear (HP:0000378) | 1.97612488 |
109 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97422795 |
110 | Myokymia (HP:0002411) | 1.97303944 |
111 | Gaze-evoked nystagmus (HP:0000640) | 1.97042593 |
112 | Broad-based gait (HP:0002136) | 1.96791379 |
113 | Prolonged neonatal jaundice (HP:0006579) | 1.96059050 |
114 | Mitochondrial inheritance (HP:0001427) | 1.94763973 |
115 | Hypoproteinemia (HP:0003075) | 1.94195558 |
116 | Renal Fanconi syndrome (HP:0001994) | 1.93635775 |
117 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.93419008 |
118 | Progressive macrocephaly (HP:0004481) | 1.92595950 |
119 | Focal dystonia (HP:0004373) | 1.92388835 |
120 | Coronal craniosynostosis (HP:0004440) | 1.91390183 |
121 | Limb dystonia (HP:0002451) | 1.89241027 |
122 | Humeroradial synostosis (HP:0003041) | 1.89078092 |
123 | Synostosis involving the elbow (HP:0003938) | 1.89078092 |
124 | Memory impairment (HP:0002354) | 1.88313999 |
125 | Spastic paraparesis (HP:0002313) | 1.87727125 |
126 | Status epilepticus (HP:0002133) | 1.87371065 |
127 | Muscular hypotonia of the trunk (HP:0008936) | 1.86585330 |
128 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.85491704 |
129 | Foot dorsiflexor weakness (HP:0009027) | 1.84832519 |
130 | Paraplegia (HP:0010550) | 1.83757290 |
131 | Spastic paraplegia (HP:0001258) | 1.83677043 |
132 | Partial duplication of thumb phalanx (HP:0009944) | 1.82255308 |
133 | IgG deficiency (HP:0004315) | 1.82161100 |
134 | Gowers sign (HP:0003391) | 1.80777027 |
135 | Congenital primary aphakia (HP:0007707) | 1.80547985 |
136 | Epiphyseal dysplasia (HP:0002656) | 1.80420148 |
137 | Metabolic alkalosis (HP:0200114) | 1.79952241 |
138 | Erythroderma (HP:0001019) | 1.79510329 |
139 | Septo-optic dysplasia (HP:0100842) | 1.77489932 |
140 | Absent speech (HP:0001344) | 1.77232319 |
141 | Craniofacial dystonia (HP:0012179) | 1.74184200 |
142 | Hepatocellular necrosis (HP:0001404) | 1.74139052 |
143 | Increased CSF protein (HP:0002922) | 1.73979107 |
144 | Acute encephalopathy (HP:0006846) | 1.73035154 |
145 | Rigidity (HP:0002063) | 1.71879979 |
146 | Mixed hearing impairment (HP:0000410) | 1.71504482 |
147 | Bradykinesia (HP:0002067) | 1.71488860 |
148 | Dysarthria (HP:0001260) | 1.71425892 |
149 | Hypokalemic alkalosis (HP:0001949) | 1.71163514 |
150 | Epileptiform EEG discharges (HP:0011182) | 1.70997804 |
151 | Progressive inability to walk (HP:0002505) | 1.70542198 |
152 | Abnormal hair whorl (HP:0010721) | 1.69770918 |
153 | Impaired vibratory sensation (HP:0002495) | 1.69721933 |
154 | Hypomagnesemia (HP:0002917) | 1.68806621 |
155 | Upper limb muscle weakness (HP:0003484) | 1.68442326 |
156 | Barrel-shaped chest (HP:0001552) | 1.67906849 |
157 | Infantile muscular hypotonia (HP:0008947) | 1.66420216 |
158 | Muscle fiber splitting (HP:0003555) | 1.66196427 |
159 | Abnormality of the foot musculature (HP:0001436) | 1.64823820 |
160 | Stomatitis (HP:0010280) | 1.64705161 |
161 | Postnatal microcephaly (HP:0005484) | 1.64563695 |
162 | Confusion (HP:0001289) | 1.64506649 |
163 | Abnormality of the 2nd finger (HP:0004100) | 1.64441890 |
164 | Gait ataxia (HP:0002066) | 1.64037370 |
165 | Diminished movement (HP:0002374) | 1.63998374 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 5.75187714 |
2 | OXSR1 | 4.02135811 |
3 | PBK | 3.13251145 |
4 | BCR | 2.96836249 |
5 | EPHB1 | 2.93129698 |
6 | NTRK3 | 2.90563128 |
7 | LIMK1 | 2.89327678 |
8 | CASK | 2.72539628 |
9 | MST4 | 2.57906405 |
10 | MAPKAPK5 | 2.55346108 |
11 | PKN1 | 2.52321064 |
12 | CDK19 | 2.30754927 |
13 | TNIK | 2.15436446 |
14 | WNK4 | 2.10954309 |
15 | MAP3K12 | 2.01328327 |
16 | PRPF4B | 1.99244938 |
17 | TESK2 | 1.95858780 |
18 | DAPK2 | 1.94033348 |
19 | MINK1 | 1.90609540 |
20 | MET | 1.86213835 |
21 | TRIM28 | 1.81901774 |
22 | FGFR2 | 1.81631050 |
23 | CAMKK2 | 1.72496721 |
24 | NEK6 | 1.66186621 |
25 | PRKD3 | 1.52997668 |
26 | CSNK1G3 | 1.51208039 |
27 | MAP3K4 | 1.49642083 |
28 | CLK1 | 1.49516842 |
29 | NTRK1 | 1.47833547 |
30 | CAMK2B | 1.46114910 |
31 | UHMK1 | 1.44939845 |
32 | PINK1 | 1.43603053 |
33 | CAMKK1 | 1.42372340 |
34 | EIF2AK3 | 1.41468284 |
35 | CSNK1A1L | 1.37865379 |
36 | ROCK2 | 1.36122389 |
37 | MUSK | 1.35388769 |
38 | WNK1 | 1.31573477 |
39 | MAP4K2 | 1.30306887 |
40 | ERBB3 | 1.29306098 |
41 | CAMK2D | 1.24121873 |
42 | SGK223 | 1.19667815 |
43 | SGK494 | 1.19667815 |
44 | TSSK6 | 1.18739813 |
45 | DAPK1 | 1.17186538 |
46 | BMPR1B | 1.15930382 |
47 | CSNK1G1 | 1.13508219 |
48 | DYRK2 | 1.11494960 |
49 | TRPM7 | 1.11196489 |
50 | BUB1 | 1.00376939 |
51 | FGR | 0.99890981 |
52 | CAMK2G | 0.98940620 |
53 | PRKCG | 0.98697453 |
54 | CSNK1G2 | 0.92299938 |
55 | ARAF | 0.88743295 |
56 | PRKCE | 0.87801633 |
57 | PDK2 | 0.86956972 |
58 | MAP2K7 | 0.86348551 |
59 | MAP3K9 | 0.86171404 |
60 | CDK14 | 0.86161720 |
61 | GRK5 | 0.85018833 |
62 | TXK | 0.85005105 |
63 | MKNK1 | 0.84875721 |
64 | CAMK2A | 0.84319327 |
65 | ERBB4 | 0.84191118 |
66 | MAP3K13 | 0.83886599 |
67 | ITK | 0.82970704 |
68 | PLK2 | 0.82316997 |
69 | PAK3 | 0.81545916 |
70 | BMPR2 | 0.81372618 |
71 | ADRBK2 | 0.81307083 |
72 | FGFR1 | 0.81265675 |
73 | PRKCQ | 0.79965362 |
74 | MAPK13 | 0.79496531 |
75 | IRAK2 | 0.79129925 |
76 | KDR | 0.78321218 |
77 | IRAK1 | 0.76850065 |
78 | GRK7 | 0.76111479 |
79 | SIK3 | 0.75029874 |
80 | MAPK15 | 0.74728593 |
81 | MAP3K14 | 0.74267005 |
82 | EPHA4 | 0.72690184 |
83 | MARK1 | 0.70641982 |
84 | CDK18 | 0.69474744 |
85 | CDK15 | 0.68834693 |
86 | DAPK3 | 0.67732194 |
87 | BRSK1 | 0.67701469 |
88 | ILK | 0.67246273 |
89 | JAK1 | 0.63685275 |
90 | WNK3 | 0.60702702 |
91 | CDK5 | 0.60556502 |
92 | CDK11A | 0.60499846 |
93 | ACVR1B | 0.60175119 |
94 | BLK | 0.60007285 |
95 | ALK | 0.59487156 |
96 | TESK1 | 0.58573349 |
97 | PAK6 | 0.58320850 |
98 | STK16 | 0.57514365 |
99 | FRK | 0.56895809 |
100 | PHKG1 | 0.56724753 |
101 | PHKG2 | 0.56724753 |
102 | MAPK10 | 0.55451539 |
103 | IRAK4 | 0.55345514 |
104 | FES | 0.55057128 |
105 | VRK1 | 0.54688571 |
106 | INSRR | 0.53515351 |
107 | TYRO3 | 0.53394710 |
108 | PRKD1 | 0.52736178 |
109 | KSR1 | 0.50306296 |
110 | OBSCN | 0.49373512 |
111 | RPS6KA5 | 0.49134256 |
112 | PLK3 | 0.48560228 |
113 | PIK3CA | 0.46562538 |
114 | PRKG1 | 0.45705892 |
115 | PIM2 | 0.43701263 |
116 | CSNK1A1 | 0.43386386 |
117 | SGK1 | 0.43062623 |
118 | CAMK1 | 0.42320589 |
119 | RPS6KA3 | 0.42222863 |
120 | FYN | 0.42055802 |
121 | NME1 | 0.41232250 |
122 | EPHA3 | 0.40291503 |
123 | EIF2AK2 | 0.40057206 |
124 | PRKCA | 0.39180543 |
125 | YES1 | 0.37878162 |
126 | NTRK2 | 0.33534961 |
127 | MOS | 0.33297706 |
128 | MARK2 | 0.32755209 |
129 | PDPK1 | 0.32307863 |
130 | ICK | 0.31679906 |
131 | ADRBK1 | 0.30485915 |
132 | DYRK1A | 0.29348193 |
133 | GSK3A | 0.28509280 |
134 | PAK1 | 0.28179503 |
135 | IKBKB | 0.27791706 |
136 | PRKACA | 0.27083598 |
137 | LCK | 0.26773378 |
138 | PNCK | 0.26036230 |
139 | ROCK1 | 0.23947586 |
140 | MKNK2 | 0.23469394 |
141 | MAPKAPK2 | 0.22954266 |
142 | PRKCH | 0.22267606 |
143 | PRKACB | 0.22175517 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.48123297 |
2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.40954938 |
3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.12010782 |
4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.41735404 |
5 | Protein export_Homo sapiens_hsa03060 | 3.03335389 |
6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.00312112 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.66532096 |
8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.65818516 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45358509 |
10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.34526125 |
11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.26626934 |
12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.04319508 |
13 | Insulin secretion_Homo sapiens_hsa04911 | 1.95981394 |
14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.91744218 |
15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.90460094 |
16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89065090 |
17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.88864081 |
18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.85988740 |
19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.75957892 |
20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.72278586 |
21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.69500737 |
22 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.67613374 |
23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63067341 |
24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.59015493 |
25 | Axon guidance_Homo sapiens_hsa04360 | 1.56987508 |
26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45440902 |
27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44553893 |
28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41346205 |
29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.41043378 |
30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38013179 |
31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.37181592 |
32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34127320 |
33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.33022499 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31166353 |
35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29739260 |
36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.28915803 |
37 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.24344289 |
38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21480616 |
39 | Phagosome_Homo sapiens_hsa04145 | 1.17829630 |
40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17423959 |
41 | Allograft rejection_Homo sapiens_hsa05330 | 1.16504658 |
42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15594208 |
43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13641624 |
44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13226877 |
45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.10982404 |
46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.10558818 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09190180 |
48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05454895 |
49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02549328 |
50 | Huntingtons disease_Homo sapiens_hsa05016 | 1.02253464 |
51 | Malaria_Homo sapiens_hsa05144 | 1.01683518 |
52 | Long-term depression_Homo sapiens_hsa04730 | 1.01289687 |
53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96560878 |
54 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.95389081 |
55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92407950 |
56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.90025117 |
57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89852822 |
58 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87321280 |
59 | Phototransduction_Homo sapiens_hsa04744 | 0.87055095 |
60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86775587 |
61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85995946 |
62 | Proteasome_Homo sapiens_hsa03050 | 0.85948991 |
63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.85403408 |
64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84462615 |
65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83674699 |
66 | Lysosome_Homo sapiens_hsa04142 | 0.83266817 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82561943 |
68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82475926 |
69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81421900 |
70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.81326745 |
71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81100779 |
72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80087784 |
73 | Asthma_Homo sapiens_hsa05310 | 0.75755965 |
74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74747114 |
75 | Tight junction_Homo sapiens_hsa04530 | 0.74465740 |
76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73941518 |
77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72513302 |
78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72362281 |
79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71870783 |
80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71645617 |
81 | Morphine addiction_Homo sapiens_hsa05032 | 0.71267625 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.70336310 |
83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69028551 |
84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68415268 |
85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65899429 |
86 | Salmonella infection_Homo sapiens_hsa05132 | 0.60388146 |
87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58716725 |
88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58543828 |
89 | Endocytosis_Homo sapiens_hsa04144 | 0.58502207 |
90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57604787 |
91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55684101 |
92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55058902 |
93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53990594 |
94 | Gap junction_Homo sapiens_hsa04540 | 0.53978788 |
95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50300512 |
96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48789927 |
97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48198619 |
98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47489081 |
99 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47013937 |
100 | Pertussis_Homo sapiens_hsa05133 | 0.46612829 |
101 | Mineral absorption_Homo sapiens_hsa04978 | 0.46139773 |
102 | Bile secretion_Homo sapiens_hsa04976 | 0.45857528 |
103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45656025 |
104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45433083 |
105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43449332 |
106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43418940 |
107 | ABC transporters_Homo sapiens_hsa02010 | 0.42799923 |
108 | Nicotine addiction_Homo sapiens_hsa05033 | 0.42759420 |
109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42053037 |
110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41828739 |
111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40626402 |
112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40484742 |
113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39967305 |
114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39347950 |
115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39012786 |
116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35793145 |
117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.35784389 |
118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35624563 |
119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35298196 |
120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35132858 |
121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34324050 |
122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34298668 |
123 | Peroxisome_Homo sapiens_hsa04146 | 0.33507399 |
124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33226119 |
125 | Glioma_Homo sapiens_hsa05214 | 0.32428254 |
126 | RNA polymerase_Homo sapiens_hsa03020 | 0.32288655 |
127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31619509 |
128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30861973 |
129 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30187067 |
130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29893361 |
131 | Melanogenesis_Homo sapiens_hsa04916 | 0.29864488 |
132 | Shigellosis_Homo sapiens_hsa05131 | 0.29701652 |
133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29121949 |
134 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28582446 |
135 | Salivary secretion_Homo sapiens_hsa04970 | 0.28141194 |
136 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27917383 |
137 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.27059791 |
138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24086041 |
139 | Taste transduction_Homo sapiens_hsa04742 | 0.23835506 |
140 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23526334 |
141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23463712 |
142 | Renin secretion_Homo sapiens_hsa04924 | 0.23442014 |
143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23236045 |